ProfileGDS5678 / 1434730_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 58% 57% 57% 55% 58% 62% 61% 57% 56% 56% 59% 56% 57% 57% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.5529158
GSM967853U87-EV human glioblastoma xenograft - Control 23.4572857
GSM967854U87-EV human glioblastoma xenograft - Control 33.4524857
GSM967855U87-EV human glioblastoma xenograft - Control 43.336155
GSM967856U87-EV human glioblastoma xenograft - Control 53.4418358
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.7635862
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.7217461
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.44557
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.3866256
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.4161856
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.545159
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.3942156
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.4805557
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.456757